This webinar covers the status of Covid-19 in Asia-Pacific and the factors that have driven the relatively low spread, regulatory guidance and acceptability of remote monitoring, as well as risk strategies and other actions to ensure clinical trial continuity.
Sponsored by Novotech, the panel includes Alex Richart MD (vice president of clinical development at TG Therapeutics), Yooni Kim (executive director of Asia operations for Novotech), Daniela Caiazza (director of clinical operations ANZ), Hannah Tarrant (Novotech project director), and Kristyn Munro (director of business development operations).Enter your details here to receive your free webinar..